Skip to main content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.

Hexetidine

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A01AB12

CAS registry number (Chemical Abstracts Service)

0000141-94-6

Chemical Formula

C21-H45-N3

Molecular Weight

340

Therapeutic Categories

Antiseptic agent

Disinfectant

Chemical Name

5-Pyrimidinamine, 1,3-bis(2-etylhexyl)hexahydro-5-metyl-

Foreign Names

  • Hexetidinum (Latin)
  • Hexetidin (German)
  • Hexétidine (French)
  • Hexetidina (Spanish)

Generic Names

  • Esetidina (OS: DCIT)
  • Hexetidine (OS: BAN)
  • Hexétidine (OS: DCF)
  • Hexetidin (PH: Ph. Eur. 9)
  • Hexetidine (PH: BP 2018, Ph. Eur. 9)
  • Hexétidine (PH: Ph. Eur. 9)
  • Hexetidinum (PH: Ph. Eur. 9)

Brand Names

  • Abrasone [+ Fluocinonide, + Ruscogenin]
    Anotaciones Farmaceuticas, Spain
  • Actiseptic
    Johnson & Johnson, Italy
  • Anso [+ Triamcinolone, + Lidocaine, + Pentosan]
    Lacer SA, Hong Kong
  • Bactidol
    Johnson & Johnson, Hong Kong; Johnson & Johnson, Philippines; Johnson & Johnson, Singapore
  • Belosept
    Belupo, Croatia (Hrvatska)
  • Buchex Forte [+ Benzydamine]
    Bernabo, Argentina
  • Buco
    Celsius, Uruguay
  • Bucosept
    Neo-Fármaco, Ecuador
  • Collu-Hextril
    Johnson & Johnson, Portugal
  • Drossadin 0,1%
    Drossapharm, Switzerland
  • Drossadin 0,2%
    Drossapharm, Switzerland
  • Duphaderm [+ Prednisolone] [veterinary use]
    Zoetis, France
  • Duranil
    Elea, Argentina
  • Ephaldene 0.1%
    Western, Egypt
  • Hekzoton
    Drogsan, Turkey
  • Hexabain
    Siphat, Tunisia
  • Hexadol
    Otto Pharmaceutical, Indonesia
  • Hexalen
    Johnson & Johnson, Greece; Johnson & Johnson Hellas, Cyprus
  • Hexalen 0.1%
    Johnson & Johnson, Greece; Johnson & Johnson Hellas, Cyprus
  • Hexalen 0.2%
    Johnson & Johnson, Greece; Johnson & Johnson Hellas, Cyprus
  • Hexétidine Biogaran Conseil 0.1%
    Biogaran, France
  • Hexétidine EG Labo Conseil 0.1%
    EG Labo, France
  • Hexétidine H2 Pharma 0.1%
    H2Pharma, France
  • Hexétidine Sandoz Conseil 0.1%
    Sandoz, France
  • Hexétidine Teva Conseil 0.1%
    Teva Santé, France
  • Hexocil [veterinary use]
    Pharmaxim vet, Finland
  • Hexoral
    Famar Orleans, Georgia; Hemofarm, Bosnia & Herzegowina; Hemofarm AD, Serbia; Janssen-Cilag Pharma, Austria; Johnson & Johnson, Germany; Johnson & Johnson, Croatia (Hrvatska); Johnson & Johnson, Latvia; Johnson & Johnson, Russian Federation; Lex ano, Lithuania; McNeil, Estonia; McNeil, Lithuania; McNeil, Romania
  • Hexoral 0.1g/100ml
    Famar Orleans, Bulgaria
  • Hexoral 0.2g/100ml
    Famar Orleans, Bulgaria
  • Hextend
    Hemofarm, Bosnia & Herzegowina
  • Hextril
    Janssen-Cilag, Switzerland; Johnson & Johnson, France; Johnson & Johnson, Portugal; Johnson & Johnson Consumer, Netherlands
  • Hextril 0.1%
    Johnson & Johnson, Belgium; Johnson & Johnson, France
  • Hextril 0.5%
    Johnson & Johnson, France
  • Hextril 5mg/5ml
    Johnson & Johnson, Luxembourg
  • Isozid-H [+ Propanol]
    Gebro Pharma, Austria
  • Mantus [+ Pentosan Polysulfate, + Triamcinolone, + Lidocaine]
    Investi, Argentina
  • Nifluril [+ Nilfumic Acid]
    UPSA, Kuwait
  • Oraldene
    Johnson & Johnson, Ireland; McNeil, Malta; McNeil Products, United Kingdom; Pfizer, Kuwait
  • Oraldene 0.1%
    Parke Davis, Egypt
  • Oraldine
    Johnson & Johnson, Ecuador; Johnson & Johnson, Uruguay; Johnson & Johnson, South Africa
  • Rinsidin
    Pharmaline, Lebanon
  • Stomatidin
    Bosnalijek, Bosnia & Herzegowina; Bosnalijek, Macedonia
  • Stopangin
    Ivax, Slovakia; Teva, Czech Republic
  • Triocil [veterinary use]
    Pharmachem, Australia; Provet, New Zealand
  • Vagi-Hex
    Assos, Turkey; Drossapharm, Switzerland; Drossapharm, Germany

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.